|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
18.620 +0.300 (+1.638%) | 2019/12 - Final RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | 2016/12 RMB(K¥) | 2015/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 18,777,096 | 3,653,739 | 3,208,668 | 9,257,964 | 13,412,333 |
| Net Cash from / (used in) Investing Activities | (6,795,967) | (5,907,624) | (3,159,653) | (1,606,454) | (1,643,322) |
| Net Cash from / (used in) Financing Activities | (13,084,565) | 10,318,519 | 3,978,885 | (2,026,964) | (7,159,751) |
| Increase / (Decrease) in Cash & Cash Equivalents | (1,103,436) | 8,064,634 | 4,027,900 | 5,624,546 | 4,609,260 |
| Cash & Cash Equivalents at beginning of period | 40,298,985 | 32,240,796 | 28,205,005 | 19,966,052 | 15,305,984 |
| Effect of Foreign Exchange Rate Changes | (3,582) | (6,445) | 7,891 | (17,839) | 50,808 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 39,191,967 | 40,298,985 | 32,240,796 | 25,572,759 | 19,966,052 |
| Remarks: | Real time quote last updated: 15/01/2021 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,895,682 |
| %Change | -2.672% |
| EPS / (LPS) | RMB 0.930 |
| NBV Per Share (¥) | RMB 16.653 |